Cytek Biosciences, Inc. CTKB Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s deferred tax assets?
- Cytek Biosciences, Inc. (CTKB) reported deferred tax assets of -$183K in Q1 2026.
- How has Cytek Biosciences, Inc.'s deferred tax assets changed year-over-year?
- Cytek Biosciences, Inc.'s deferred tax assets decreased by 100.5% year-over-year, from $33.71M to -$183K.
- What is the long-term trend for Cytek Biosciences, Inc.'s deferred tax assets?
- Over 5 years (2020 to 2025), Cytek Biosciences, Inc.'s deferred tax assets has grown at a -100.0% compound annual growth rate (CAGR), from $7.38M to $0.
- What does deferred tax assets mean?
- Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.